Public Release: 

EMBO at Basel Life, a new conference on current and emerging life science research

EMBO

Basel and Heidelberg, 6 September 2017 - EMBO and Basel Life are pleased to announce the EMBO at Basel Life conference, taking place at the Congress Center Basel, Switzerland from 10-13 September 2017. A committee of leading scientists has organized this international and broad-scope scientific conference on current and emerging life science research to be held as part of Basel Life.

"Established and young researchers will present and discuss work on all aspects of genome biology, ranging from microbial genomes and genome evolution to transcription, inheritance and clinical approaches," stated EMBO Director Maria Leptin. Presentations on approaches and techniques, including single molecule imaging and bio-informatics, will complete the programme.

The conference will bring the best in fundamental research to a wide audience, ranging from leading experts in their fields to students and young researchers at the beginning of their careers. "It aims to foster a fruitful exchange between researchers from academia, clinics, the pharmaceutical and biotech industry, and it will promote excellence in the life sciences," said Susan Gasser from Friedrich Miescher Institute for Biomedical Research, Basel, and a scientific organizer of the conference.

Nobel laureate Sir Paul Nurse will deliver a public lecture on the control of the cell cycle. Jennifer Doudna and Svante Pääbo will deliver the keynote lectures. Jennifer Doudna, co-discoverer of the CRISPR-Cas9 technology, will discuss the genome engineering revolution, while Svante Pääbo will talk about illuminating the origins of modern humans through sequencing ancient genomes.

With the Louis-Jeantet Prize lectures, the conference will celebrate the achievements of the 2017 prize winners: Neurobiologist Silvia Arber and immunologist Caetano Reis e Sousa will present their research on movement-controlling neuronal circuits and the mechanisms for sensing pathogen invasion and tissue damage, respectively.

During two science policy sessions the speakers will be discussing open science and open data: What is the role of publishers in open science? What do outbreaks and epidemics tell us about the need for making data openly available? And what are the issues and ethics that need to be considered when potentially sharing personally identifiable data?

For the full programme and the speaker's list, please visit https://www.basellife.org/embo.

To follow the live stream from the opening lecture by Sir Paul Nurse, Francis Crick Institute, London, on 10 September at 18:00 CET made available by the Corporate sponsor Roche, please visit http://www.roche.com/research_and_development/science-and-the-city/basel-life.htm

###

About EMBO

EMBO is an organization of more than 1700 leading researchers that promotes excellence in the life sciences. The major goals of the organization are to support talented researchers at all stages of their careers, stimulate the exchange of scientific information, and help build a European research environment where scientists can achieve their best work.

EMBO helps young scientists to advance their research, promote their international reputations and ensure their mobility. Courses, workshops, conferences and scientific journals disseminate the latest research and offer training in techniques to maintain high standards of excellence in research practice. EMBO helps to shape science and research policy by seeking input and feedback from our community and by following closely the trends in science in Europe. ?For more information: http://www.embo.org

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.